
Sign up to save your podcasts
Or


Based on Podcast App listening data
Hello dear ones! I am over the moon and beyond grateful to share this next episode with you, where I got to interview one of my herbal teachers. We go deep into clinical pearls from this super-experienced powerhouse of a woman who’d like you to take away the following bottom line: the herbs are here to help heal us, they’re inexpensive, safe and easy to use.
What does the IRA really achieve when it comes to prescription medications? What are its effects on independent pharmacies, the 340B program, or even DIR fees? What parts of the equation are missing, and what inclusions would make the IRA better for everyone?
Listen in as PUTTcast hosts Monique Whitney and Lauren Young take a deep dive into the answers to these questions and many more with special guest American Pharmacies General Counsel, Miguel Rodriguez.
Ketamine is among the most unique pharmaceutical agents on the market. Join us on an exploration of the research on its neuropharmacology and use for depression, and discussion of risks and benefits.
References:
Article referenced in the beginning:
Martinez-Marmol, et al. Hericerin derivatives activates a pan neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spacial memory. Journal of Neurochemistry. 2023(165);6: 791-808
Ballard E and Zarate C. The role of disassociation in ketamine’s anti-depressant effects. Nature Communications. 2020: 6431
Bobo WV, et al. Ketamine for treatment resistant unipolar and bipolar major depression: Critical review and implications for clinical practice. Depression and Anxiety. 6 April 2016.
Esketamine [package insert]. Janssen Neuroscience. July 2023.
Fava M, et al. Double blind, placebo controlled dose ranging trial of intravenous ketamine as adjunctive therapy in treatment resistant depression (TRD). Molecular Psychiatry. 2020(25): 1592-1603
Gales A, Maxwell S. Ketamine: recent evidence and clinical uses. World Federation of Societies of Anesthesiologists. 12 June 2018.
Johnston JN, et al. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology. 2023
Loo CK, et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular, and subcutaneous routes for ketamine in depression. Acta Psychiatria Scandinavica. 30 March 2016.
Mandal S, et al. Efficacy of Ketamine therapy in the treatment of depression. Indian Journal of Psychiatry. 2019 Sept-Oct; 61(5).
VA/DoD Clinical Practice Guideline. (2022). The Management of Major Depressive Disorder. Washington, DC: U.S. Government Printing Office
In this episode, host Mark Fulton and guest Patrick Hussey talk about emerging trends in pharmacy and what the future will look like for LTC pharmacy operators. They highlight both new opportunities and challenges from a regulatory, technological and practice evolution perspective.
https://www.japha.org/article/S1544-3191(23)00028-6/fulltext
"Hannah Palsgraf went to pharmacy school at Albany College of Pharmacy in upstate NY. She completed her PGY1 at John R. Oishei Children's Hospital in Buffalo, NY and went on to complete her PGY2 in pediatrics through Philadelphia College of Pharmacy with the practice site at Children's Regional Hospital at Cooper in Camden, NJ. She currently practices as a Neonatal ICU Clinical Pharmacy Specialist at Cohen Children's Medical Center in New Hyde Park, NY on Long Island."
Meet Trent Voelkl of Buffalo Pharmacies, who we consider the original gangster, the fusion innovator of all things home care and pharmacy. We discuss the differences and appropriate options of medication management solutions in the home, how to approach independent living facilities to earn their business, how to refer private pay business to your own company and much more!
From the publisher's feed
Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.
Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.
Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.
PPN is a division of RxPR, LLC. Copyright 2026
Ranked by our users in the last 21 days

261 Listeners

111,845 Listeners

56,468 Listeners

559 Listeners

402 Listeners

4,866 Listeners

164,572 Listeners

133 Listeners

3,045 Listeners

2,204 Listeners

19,285 Listeners

33 Listeners

166 Listeners

0 Listeners